|
ethyl (S)-4-((3,5-dichloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylate
|
乙基（S）-4-（（3,5-二氯-4-甲氧基芐基）氨基）-2-（2-（羥甲基）吡咯烷-1-基）嘧啶-5-羧酸酯（阿伐那非雜質(zhì)）
|
2520114-19-4
|
|
Valsartan Impurity 89
|
纈沙坦雜質(zhì)89
|
136304-93-3
|
|
diethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate
|
奧美沙坦酯雜質(zhì)R
|
144690-53-9
|
|
5-CARBETHOXYURACIL
|
5-尿嘧啶甲酸乙酯（阿伐那非雜質(zhì)）
|
28485-17-8
|
|
N1-ethyl-N2-(4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2-yl)ethane-1,2-diamine hydrochloride
|
布南色林雜質(zhì)05
|
2243798-59-4
|
|
(S)-4-((3,5-dichloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid
|
（S） -4-（（3,5-二氯-4-甲氧基芐基）氨基）-2-（2-（羥甲基）吡咯烷-1-基）嘧啶-5-羧酸（阿伐那非雜質(zhì)）
|
1643811-26-0
|
|
Cycloocta[b]pyridine, 2-chloro-4-(3-fluorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì) 28(16)
|
132813-15-1
|
|
INDEX NAME NOT YET ASSIGNED
|
達(dá)比加群酯雜質(zhì)
|
2518152-88-8
|
|
2-Pyrimidinamine, N-(2,4-dimethoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-
|
奧西替尼雜質(zhì)
|
1942853-78-2
|
|
1-Piperazinecarboxylic acid, 4-[3-methoxy-4-[[2-[[3-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-, 1,1-dimethylethyl ester
|
CO1686雜質(zhì)
|
2120319-14-2
|
|
2-Chloro-4-(4-fluorophenyl)-5，6，7，8，9，10-hexahydrocycloocta[b]pyridine
|
2-氯-4-(4-氟苯基)-5，6，7，8，9，10-六氫環(huán)辛烷并[b]吡啶(布南色林雜質(zhì))
|
132813-14-0
|
|
Dabigatran iMpurity O
|
達(dá)比加群雜質(zhì)O
|
948551-71-1
|
|
ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
|
達(dá)比加群雜質(zhì)J
|
1354727-65-3
|
|
Avanafil Impurity R-2
|
阿伐那非雜質(zhì)R-2
|
38057-59-9
|
|
Blonanserin Impurity I
|
布南色林雜質(zhì)I
|
49860-76-6
|
|
Dabigatran Impurity 38
|
達(dá)比加群雜質(zhì)38
|
1416446-40-6
|
|
β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester
|
達(dá)比加群甲酯雜質(zhì)
|
771459-37-1
|
|
N-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine
|
尼達(dá)尼布雜質(zhì)
|
652140-02-8
|
|
Cycloocta[b]pyridin-2-amine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì)12
|
2518376-10-6
|
|
methyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl) propanoate hydrochloride
|
立他司特雜質(zhì)
|
2758051-12-4
|
|
2-Propenamide, N-[3-[[4-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]phenyl]-
|
CO1686雜質(zhì)
|
1888303-01-2
|
|
Dabigatran Impurity 18
|
達(dá)比加群雜質(zhì) 18
|
1422435-35-5
|
|
DMDO
|
4,5-二甲基-1,3-二氧雜環(huán)戊烯-2-酮（奧美沙坦相關(guān)化合物）
|
37830-90-3
|
|
(R)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoic acid
|
(R)-2-氨基-3-(3-(甲基磺?；?苯基)丙酸
|
1270132-45-0
|
|
Olmesartan Impurity 52
|
奧美沙坦雜質(zhì)52
|
58954-23-7
|
|
Nintedanib-013-CO
|
尼達(dá)尼布標(biāo)準(zhǔn)品-CO
|
2218446-42-3
|
|
midazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-hydroxyphenyl)-5-methyl-7-propyl-
|
伐地那非雜質(zhì)
|
910554-78-8
|
|
1H-Imidazole-4-carboxylic acid, 5-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
|
奧美沙坦酯雜質(zhì)
|
1048948-20-4
|
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-5,7-dimethyl-
|
伐地那非雜質(zhì)
|
224785-72-2
|
|
5,7-dichloro-1,2,3,4-tetrahydroisoquinoline
|
5,7-二氯-1,2,3,4-四氫異喹啉鹽酸鹽（立他司特雜質(zhì)）
|
89315-56-0
|
|
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid
|
尼達(dá)尼布雜質(zhì)17
|
1253768-91-0
|
|
3-Amino-4-(carboxymethyl)benzoic acid
|
3-氨基-4-(羧甲基)苯甲酸（尼達(dá)尼布雜質(zhì)）
|
1373232-85-9
|
|
Boc-3-(Methylsulfonyl)-L-Phenylalanine
|
(S)-2-((叔丁氧羰基)氨基)-3-(3-(甲基磺酰基)苯基)丙酸(立他司特雜質(zhì)C-1)
|
1289646-76-9
|
|
5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole
|
N-(三苯基甲基)-5-(4'-甲基聯(lián)苯-2-基)四氮唑（奧美沙坦相關(guān)化合物）
|
124750-53-4
|
|
Blonanserin Impurity 18
|
布南色林雜質(zhì) 18
|
1477480-40-2
|
|
1-Piperazinecarboxylic acid, 4-[2-[methyl(4-nitrophenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester
|
尼達(dá)尼布雜質(zhì)
|
1277571-69-3
|
|
β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester
|
達(dá)比加群酯雜質(zhì)
|
1873316-88-1
|
|
Blonanserin Impurity 15
|
布南色林雜質(zhì)15
|
132813-16-2
|
|
2-Propenenitrile, 3-amino-3-(3-fluorophenyl)-
|
布南色林雜質(zhì)
|
71682-85-4
|
|
4-(2-Cyanophenyl)benzyl alcohol
|
4-(2-氰基苯基)芐醇
|
154709-19-0
|
|
Blonanserin iMpurity
|
布南色林雜質(zhì)
|
132810-83-4
|
|
Desfluoro Hydroxy Blonanserin
|
布南色林雜質(zhì)
|
132812-29-4
|
|
1,3-Benzenediamine, 4,6-dimethoxy-N1-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-
|
奧西替尼雜質(zhì)
|
1942853-79-3
|
|
ifitegrast impurity C
|
立他司特雜質(zhì) C
|
851785-70-1
|
|
2'-(Triphenylmethyltetrazol-5-yl)biphenyl-4-yl]carboxaldehyde;Olmesartan Impurity 81
|
奧美沙坦雜質(zhì) 81
|
155983-56-5
|
|
Dabigatran Impurity 10 (DABRC-10)
|
達(dá)比加群雜質(zhì)10(DABRC-10)
|
1304574-20-6
|
|
Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]-
|
塞來昔布雜質(zhì)
|
1135952-91-8
|
|
4-hydroxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazine-2-yl)phenylsulfonic acid
|
伐地那非雜質(zhì)
|
910554-77-7
|
|
N-(4-Nitrophenyl)-2,2,2-trichloroacetamide
|
尼達(dá)尼布雜質(zhì)
|
4306-32-5
|
|
Lifitegrast Impurity 51
|
立他司特雜質(zhì)51
|
2177264-60-5
|
|
Dabigatran Etexilate iMpurity C4
|
鄰丁基達(dá)比加群乙酯(達(dá)比加群雜質(zhì))
|
1416446-43-9
|
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(2-ethoxyphenyl)-5,7-dimethyl-
|
伐地那非雜質(zhì)
|
224789-20-2
|
|
N1-(4-NITROPHENYL)-2-CHLOROACETAMIDE
|
2-氯-N-(4-硝基苯基)乙酰胺（尼達(dá)尼布雜質(zhì)）
|
17329-87-2
|
|
2-chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine 1-oxide
|
布南色林雜質(zhì)08
|
143213-96-1
|
|
2-Propenamide, N-[2,4-dimethoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
|
奧西替尼雜質(zhì)
|
1942853-18-0
|
|
Irbesartan Impurity 24
|
厄貝沙坦雜質(zhì)24（奧美沙坦酯雜質(zhì)）
|
2763750-28-1
|
|
1H-Indole-6-carboxylic acid, 3-[[[4-[(2-chloroacetyl)methylamino]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-, methyl ester, (3Z)-
|
尼達(dá)尼布雜質(zhì)
|
1987887-93-3
|
|
ethyl 3-(2-(chloroMethyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate
|
達(dá)比加群酯中間體3
|
1307233-94-8
|
|
Dabigatran Impurity 10
|
達(dá)比加群脂雜質(zhì)10
|
1422435-37-7
|
|
(S)-5-((Tert-butylamino)methyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one
|
利奈唑胺雜質(zhì)11
|
1215006-08-8
|
|
Linezolid Impurity 12
|
利奈唑胺雜質(zhì)12
|
1215006-11-3
|
|
1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, ethyl ester
|
尼達(dá)尼布雜質(zhì)
|
2295911-98-5
|
|
Vardenafil Impurity
|
伐地那非乙酯雜質(zhì)
|
2411340-43-5
|
|
Acetamide, N-[(3-chloro-4-methoxyphenyl)methyl]-
|
阿伐那非雜質(zhì)
|
726205-58-9
|
|
Cycloocta[b]pyridine, 2-chloro-4-(4-chlorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì) 26(14)
|
132813-22-0
|
|
5-Pyrimidinecarboxamide, 4-[[(3-chlorophenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-
|
阿伐那非雜質(zhì)
|
330786-28-2
|
|
Dabigatran Etexilate iMpurity O
|
達(dá)比加群酯雜質(zhì)O
|
1349500-09-9
|
|
Olmesartan Medoxomil Impurity 32
|
奧美沙坦酯雜質(zhì)32
|
1040405-56-8
|
|
Dabigatran iMpurity E
|
達(dá)比加群雜質(zhì)E
|
1456889-80-7
|
|
Blonanserin Impurity 10
|
布南色林雜質(zhì)10
|
132810-87-8
|
|
3-Fluorobenzoylacetonitrile
|
3-氟苯甲酰乙腈(布南色林雜質(zhì))
|
21667-61-8
|
|
N-Desethyl-N-Methyl Vardenafil
|
N-去乙基-N-甲基伐地那非（伐地那非雜質(zhì)）
|
224785-87-9
|
|
N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline
|
(3-氟-4-嗎啉-4-基苯基)氨基甲酸芐酯(利奈唑胺中間體)
|
1027135-00-7
|
|
Dabigatran Impurity 24
|
達(dá)比加群酯雜質(zhì)24（達(dá)比加群酯雜質(zhì)）
|
2243727-83-3
|
|
N-[1-[3-(2-Ethoxyphenyl)-2,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl]acetamide
|
伐地那非雜質(zhì)
|
1417529-59-9
|
|
3-amino-3-(4-fluorophenyl)propanenitrile
|
3-氨基-3-（4-氟苯基）丙腈
|
1270488-91-9
|
|
Dabigatran Impurity
|
達(dá)比加群雜質(zhì)
|
2096992-14-0
|
|
4-Amino-N-methylaniline
|
N-甲基對(duì)苯二胺（尼達(dá)尼布雜質(zhì)）
|
623-09-6
|
|
Acetamide, 2-chloro-N-methyl-N-(2-nitrophenyl)-
|
尼達(dá)尼布雜質(zhì)2
|
2653-15-8
|
|
C3-NITRO-4-METHYLAMINO-BENZOYLCHLORIDE
|
3-硝基-4-甲胺基-苯甲酰氯(達(dá)比加群雜質(zhì))
|
82357-48-0
|
|
Cycloocta[b]pyridin-2(1H)-one, 5,6,7,8,9,10-hexahydro-4-phenyl-
|
布南色林雜質(zhì)
|
132812-71-6
|
|
Acetamide, 2-hydroxy-N-methyl-N-(4-nitrophenyl)-
|
尼達(dá)尼布雜質(zhì)
|
1860012-61-8
|
|
2-Propenamide, N-[3-[[2-[[2-methoxy-4-(1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-
|
CO1686雜質(zhì)
|
2763827-03-6
|
|
N-ACETYLOXINDOLE 97
|
N-乙?；胚嵬徇_(dá)尼布雜質(zhì)）
|
21905-78-2
|
|
Dabigatran Etexilate Impurity 64
|
達(dá)比加群酯雜質(zhì)64
|
355809-32-4
|
|
Osimertinib Impurity I
|
奧西替尼雜質(zhì)I
|
2044702-55-6
|
|
2(e),4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetraazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
|
奧美沙坦酯雜質(zhì)
|
1203671-69-5
|
|
4'-(azidomethyl)-[1,1'-biphenyl]-2-carboxylic acid
|
厄貝沙坦雜質(zhì)23（奧美沙坦酯雜質(zhì)）
|
2758005-15-9
|
|
(4-ETHOXY-2-OXO-2,5-DIHYDRO-PYRROL-1-YL)-ACETIC ACID
|
4-乙氧基-2-氧代-2,5-二氫吡咯-1-基)-乙酸(奧拉西坦雜質(zhì))
|
142274-08-6
|
|
Cycloocta[b]pyridin-2(1H)-one, 4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì)
|
132812-74-9
|
|
INDEX NAME NOT YET ASSIGNED
|
2,2'-(哌嗪-1,4-二基)雙(N-甲基-N-(4-硝基苯基)乙酰胺)(尼達(dá)尼布雜質(zhì))
|
2410649-54-4
|
|
Dabigatran Etexilate Impurity 82
|
達(dá)比加群酯雜質(zhì)82
|
1771756-20-7
|
|
Ethanone, 1-[4-[4-[[2-[(3-aminophenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]-3-methoxyphenyl]-1-piperazinyl]-
|
CO1686雜質(zhì)
|
2044703-15-1
|
|
1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester
|
達(dá)比加群酯雜質(zhì)
|
1970195-83-5
|
|
Avanafil Impurity
|
阿伐那非雜質(zhì)
|
1309798-84-2
|
|
Avanafil Impurity 56
|
阿伐那非雜質(zhì)56
|
330785-82-5
|
|
Dabigatran Etexilate iMpurity D
|
達(dá)比加群酯雜質(zhì)D
|
1422435-40-2
|
|
N-[3-AMino-4-(MethylaMino)benzoyl]-N-2-pyridinyl-β-alanine Methyl Ester
|
達(dá)比加群酯雜質(zhì)
|
1369510-38-2
|
|
Dabigatran Impurity 16
|
達(dá)比加群雜質(zhì)10
|
211916-39-1
|
|
Dabigatran Impurity 19
|
達(dá)比加群雜質(zhì) 19
|
2225986-94-5
|